Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271733 · ClinicalTrials.gov registry record · NA
TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD
A NA study of PTSD, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT06271733: Completed NA study of PTSD, sponsored by Rush University Medical Center.
NCT06271733 is a NA study of PTSD that has completed, run by Rush University Medical Center. The registered enrollment target is 6 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06271733, a NA study of PTSD, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether complementing regular intensive PTSD treatment with intermittent theta burst stimulation (iTBS) applied to the right dorsolateral prefrontal cortex (DLPFC) can improve treatment response for individuals attending a 2-week intensive outpatient program (IOP) for PTSD.
Primary Outcome
Self-report measure of PTSD symptom severity. Scores range from 0 to 80, with higher scores indicating greater PTSD symptom severity.
Conditions Studied
Interventions
- DEVICE TMS
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-01-11 |
| Est. Completion | 2025-10-27 |
| Phase | NA |
What the finished NCT06271733 record still lists
NCT06271733 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (98% lower).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which TMS is the first listed.
NCT06271733 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06271733 about?
NCT06271733 is a clinical study titled "TMS for Veterans Attending a 2-week Intensive Outpatient Program for PTSD". The goal of this study is to determine whether complementing regular intensive PTSD treatment with intermittent theta burst stimulation (iTBS) applied to the right dorsolateral prefrontal cortex (DLPFC) can improve treatment response for individuals attending a 2-week intensive outpatient program (I...
What is the current status of trial NCT06271733?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-01-11. Estimated completion is 2025-10-27.
What conditions does trial NCT06271733 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT06271733?
The interventions under investigation include: TMS (DEVICE).
Who is sponsoring clinical trial NCT06271733?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06271733 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06271733's enrollment target sits among peer trials
6 154th of 154 the lowest of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI